Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Surgical Endoscopy
Published in: Surgical Endoscopy 12/2016

01-12-2016

Neoplastic Barrett’s oesophagus and long-term follow-up after endoscopic therapy: complete histological eradication of Barrett associated with high-grade dysplasia significantly decreases neoplasia relapse

Authors: Fabrice Caillol, Sebastien Godat, Aurelie Autret, Erwan Bories, Christian Pesenti, Jean Phillippe Ratone, Flora Poizat, Jerome Guiramand, Jean Robert Delpero, Marc Giovannini

Published in: Surgical Endoscopy | Issue 12/2016

Login to get access

Abstract

Background and aims

Endotherapy (ET) has replaced surgery as the first-line treatment of high-grade dysplasia (HGD)/superficial ECA (ECAs) from Barrett’s oesophagus (BO). However, long-term follow-up and predictive factors of relapse are not so well studied. The aim of the following study was to evaluate the efficiency of ET for treatment of HGD/ECAs and to determine factors of long-term efficiency.

Methods

ET procedures were manually reported and registered in a hospital data base from March 2000 to July 2010. Inclusion criteria were HGD/ECA on pre-resection biopsies, complete histological and sufficient oncological resection of HGD/ECAs, and complete macroscopic resection of metaplastic BO. Sixty patients (53 men, mean age = 65 years) were included.

Results

Median follow-up was 66 months [range 42–80]. Complete eradication of residual histological metaplastic BO occurred in 29 patients (48 %). Relapse rate at 36 months was 16.6 % (n = 10) and was unchanged at 60 months of follow-up. There was only one relapse (3.4 %) in case of complete eradication of metaplastic BO and 9 (31 %) in case of incomplete eradication. In univaried and multi-varied analysis, complete eradication of metaplastic BO (p < 0.05) and BO length <5 cm (p < 0.05) were predictive of neoplastic BO non relapse. The length of BO remained a prognostic factor for disease-free survival (DFS). When these preponderant data were cancelled out in multi-varied analysis, complete eradication of BO was a prognostic factor for DFS (p < 0.05).

Conclusion

Complete histological eradication of BO by ET significantly decreases the rate of neoplasia relapse.
Literature
1.
Sampliner RE (2002) Updated guidelines for the diagnosis, surveillance, and therapy of Barrett’s esophagus. Am J Gastroenterol 97:1888–1895CrossRefPubMed
2.
Birmeyer JD, Stukel TA, Siewers AE et al (2003) Surgeon volume and operative mortality in the united states. N Engl J Med 349:2117–2127CrossRef
3.
Thomas P, Doddoli C, Neville P et al (1996) Esophageal cancer resection in the elderly. Eur J Cardiothorac Surg 11:941–946CrossRef
4.
Lopes CV, Hela M, Pesenti C, Bories E, Caillol F, Monges G, Giovannini M (2007) Circumferential endoscopic resection of Barrett’s esophagus with high-grade dysplasia or early adenocarcinoma. Surg Endosc 21(5):820–824CrossRefPubMed
5.
Caillol F, Bories E, Pesenti C, Poizat F, Monges G, Guiramand J, Esterni B, Giovannini M (2012) Radiofrequency ablation associated to mucosal resection in the oesophagus: experience in a single centre. Clin Res Hepatol Gastroenterol 36(4):371–377CrossRefPubMed
6.
Giovannini M, Bories E, Pesenti C, Moutardier V, Monges G, Danisi C, Lelong B, Delpero JR (2004) Circumferential endoscopic mucosal resection in Barrett’s esophagus with high-grade intraepithelial neoplasia or mucosal cancer. Preliminary results in 21 patients. Endoscopy 36(9):782–787CrossRefPubMed
7.
Pech O, Behrens A, May A et al (2008) Long-term results and risk factors analysis for recurrence after curative endoscopic therapy in 349 patients with high-grade intraepithelial neoplasia and mucosal adenocarcinoma in Barrett’s esophagus. Gut 57:1200–1206CrossRefPubMed
8.
Stein HJ, Feith M, Bruecher BL et al (2005) Early esophageal cancer: pattern of lymphatic spread and prognostic factors for long-term survival after surgical resection. Ann Surg 242:566–573PubMedPubMedCentral
9.
Zehetner J, DeMeester SR, Hagen JA et al (2011) Endoscopic resection and ablation versus esophagectomy for high-grade dysplasia and intramucosal adenocarcinoma. J Thorac Cardiovasc Surg 141(1):39–47CrossRefPubMed
10.
Pech O, Bollschweiller E, Manner H et al (2011) Comparison between endoscopic and surgical resection of mucosal esophageal adenocarcinoma in Barrett’s esophagus at two high-volume centers. Ann Surg 254:67–72CrossRefPubMed
11.
Reed MF, Tolis G Jr, Edil BH, Allan JS, Donahue DM, Gaissert HA, Moncure AC, Wain JC, Wright CD, Mathisen DJ (2005) Surgical treatment of esophageal high-grade dysplasia. Ann Thorac Surg 79:1110–1115CrossRefPubMed
12.
Wu J, Pan YM, Wang TT, Gao DJ et al (2014) Endotherapy versus surgery for early neoplasia in Barrett’s esophagus: a meta-analysis. Gastrointest Endosc 79(2):233–241CrossRefPubMed
13.
Menon D, Stafinski T, Wu H, Lau D, Wong C (2010) Endoscopic treatment for Barrett’s esophagus: a systematic review of safety and effectiveness compared to esophagectomy. BMC Gastroenterol 10:11CrossRef
14.
15.
Phoa K, Pouw RE, Bishops R et al. (2016) Multimodality endoscopic eradication for neoplastic Barrett oesophagus: results of an European multicentre study (EUROII). Gut 65(4):55–62CrossRef
16.
Anders M, Bähr C, El-Masry MA et al (2014) Long-term recurrence of neoplasia and Barrett’s epithelium after complete endoscopic resection. Gut 63:1535–1543CrossRefPubMed
17.
Phoa KN, Pouw RE, Van Vislteren FG et al (2013) Remission of Barrett’s esophagus with early neoplasia 5 years after radio frequency ablation with endoscopic resection: a Netherlands cohort study. Gastroenterology 145:96–104CrossRefPubMed
18.
Pech O, May A, Manner H et al (2014) Long-term efficacy and safety of endoscopic resection for patients with mucosal adenocarcinoma of the esophagus. Gastroenterology 146(3):652–660CrossRefPubMed
19.
Endoscopic Classification Review Group (2005) Update of the paris classification of superficial neoplastic lesions in the digestive tract. Endoscopy 37(6):570–578CrossRef
20.
Rice TW, Murthy SC, Mason DP et al (2011) Esophagectomy for clinical high-grade dysplasia. Surg J Cardiothorac Surg 40(1):113–119CrossRef
21.
22.
May A, Gossner L, Pech O et al (2002) Intraepithelial high-grade neoplasia and early adenocarcinoma in short-segment Barrett’s esophagus (SSBE): curative treatment using local endoscopic treatment techniques. Endoscopy 34(8):604–610CrossRefPubMed
23.
Peters FP, Kara MA, Rosmalen WD et al (2005) Endoscopic treatment of high-grade dysplasia and early stage cancer in Barrett’s esophagus. Gastrintest Endosc 61(4):506–514CrossRef
24.
Guarner-Argente C, Buoncristiano T, Furth EE, Falk GW, Ginsberg GG (2013) Long-term outcomes of patients with Barrett’s esophagus and high-grade dysplasia or early cancer treated with endoluminal therapies with intention to complete eradication. Gastrointest Endosc 77(2):190–199CrossRefPubMed
25.
Aida J, Vieth M, Shepherd NA et al. (2015) Is carcinoma in columnar-lined esophagus always located adjacent to intestinal metaplasia: a histologic assessment. Am J Surg Pathol 39(2):188–196CrossRefPubMed
26.
Van vilsteroy FG, Pouw RE, Seewald S et al (2011) Stepwise radical endoscopic resection versus radiofrequency ablation for Barrett’s oesophagus with high grade dysplasia or early cancer: a multicentre randomised trial. Gut 60:765–773CrossRef
27.
Weston AP, Sharma P, Banerjee S et al (2005) Visible endoscopic and histologic changes in the cardia, before and after complete Barrett’s esophagus Barrett’s esophagus ablation. Gastrointest Endosc 61:515–521CrossRefPubMed
28.
Vachard BJ, Gonzales S, Poneros JM et al (2011) Detection of intestinal metaplasia after successful eradication of Barrett’s esophagus with radiofrequency ablation. Dig Dis Sci 56:1996–2000CrossRef
29.
30.
Corley DA, Kubo A, DeBoer J, Rumore GJ (2009) Diagnosing Barrett’s esophagus: reliability of clinical and pathologic diagnoses. Gastrointest Endosc 69(6):1004–1010CrossRefPubMedPubMedCentral
31.
Shaheen NJ, Spechler SJ (2008) Total eradication of Barrett’s esophagus: study methodology, candidate selection, and clinical outcomes. Endoscopy 40(12):994–999CrossRefPubMed
32.
Wani S, Abrams J, Edmundowicz et al (2013) Endoscopic mucosal resection results in change of histologic diagnosis in Barrett’s esophagus patients with visible and flat neoplasia: a multi center cohort study. Dig Dis Sci 58(6):1703–1709CrossRefPubMedPubMedCentral
33.
Wang VS, Hornick JL, Sepulveda JA (2009) Low prevalence of submucosal invasive carcinoma at esophagectomy for high-grade dysplasia or intramucosal adenocarcinoma in Barrett’s esophagus: a 20 year experience. Gastrointest Endosc 69(4):77–783CrossRef
34.
Pouw RE, Seewald S, Gondrie JJ et al (2010) Stepwise radical endoscopic resection for eradication of Barrett’s oesophagus with early neoplasia in a cohort of 169 patients. Gut 59(9):1169–1177CrossRefPubMed
Metadata
Title
Neoplastic Barrett’s oesophagus and long-term follow-up after endoscopic therapy: complete histological eradication of Barrett associated with high-grade dysplasia significantly decreases neoplasia relapse
Authors
Fabrice Caillol
Sebastien Godat
Aurelie Autret
Erwan Bories
Christian Pesenti
Jean Phillippe Ratone
Flora Poizat
Jerome Guiramand
Jean Robert Delpero
Marc Giovannini
Publication date
01-12-2016
Publisher
Springer US
Published in
Surgical Endoscopy / Issue 12/2016
Print ISSN: 0930-2794
Electronic ISSN: 1432-2218
DOI
https://doi.org/10.1007/s00464-016-4898-6

Other articles of this Issue 12/2016

Surgical Endoscopy 12/2016 Go to the issue

OriginalPaper

Anticipation of complications after laparoscopic cholecystectomy: prediction of individual outcome

OriginalPaper

Clinical outcomes and cost–benefit analysis comparing laparoscopic and robotic colorectal surgeries

OriginalPaper

Endoscopic submucosal dissection versus surgical resection for early gastric cancer: a retrospective multicenter study on immediate and long-term outcome over 5 years

OriginalPaper

Comparison of the long-term outcomes of robotic radical gastrectomy for gastric cancer and conventional laparoscopic approach: a single institutional retrospective cohort study

OriginalPaper

Diagnostic yield of endoscopic ultrasonography-guided single-incision needle knife biopsy for gastric subepithelial tumors: comparison with resected specimens

OriginalPaper

Short-term outcomes of open versus laparoscopic surgery in elderly patients with colorectal cancer